July 5 (Reuters) - European Medicines Agency:
* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF COVID-19 VACCINE NUVAXOVID: 05/07/2022 Further company coverage:
Market Closed -
Other stock markets
|
Pre-market 07:56:56 pm | |||
13.11 USD | +47.64% | 13.02 | -0.65% |
May. 13 | Novavax Shares Pop Another 50% Following Sanofi Deal | DJ |
May. 13 | Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank... |
July 5 (Reuters) - European Medicines Agency:
* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF COVID-19 VACCINE NUVAXOVID: 05/07/2022 Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+173.12% | 1.25B | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |